• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿洛西林与阿洛西林加阿米卡星治疗重症监护病房患者严重感染的疗效比较

Azlocillin versus azlocillin plus amikacin in the treatment of severe infections in intensive care unit patients.

作者信息

Mergoni M, Stocchetti N, De Cristofaro A, Antonioni M, Zuccoli P

机构信息

Servizio di Anestesia e Rianimazione, Parma, Italy.

出版信息

Chemioterapia. 1987 Aug;6(4):286-9.

PMID:3652280
Abstract

The authors wanted to verify if in clinical practice (Intensive Care Unit patients), the association of azlocillin with an aminoglycoside offers substantial advantages compared to use of azlocillin alone. Their results show that azlocillin alone is potent enough to be used in the treatment of severe infections.

摘要

作者们想要验证,在临床实践中(重症监护病房患者),阿洛西林与一种氨基糖苷类药物联用相比单独使用阿洛西林是否具有显著优势。他们的结果表明,单独使用阿洛西林就有足够的效力用于治疗严重感染。

相似文献

1
Azlocillin versus azlocillin plus amikacin in the treatment of severe infections in intensive care unit patients.阿洛西林与阿洛西林加阿米卡星治疗重症监护病房患者严重感染的疗效比较
Chemioterapia. 1987 Aug;6(4):286-9.
2
[Treatment of acute and chronic urological infections with azlocillin--clinical and microbiological research].[阿洛西林治疗急慢性泌尿系统感染——临床与微生物学研究]
Vutr Boles. 1985;24(1):54-62.
3
[Ceftazidime with and without tobramycin versus azlocillin plus tobramycin in the therapy of bronchopulmonary infections in intensive care patients].
Infection. 1987;15 Suppl 4:S185-91. doi: 10.1007/BF01645868.
4
Treatment of severe infections in patients with cancer. The role of new acyl-penicillins.
Arch Intern Med. 1982 Oct 25;142(11):1984-7.
5
Azlocillin and the immune response in intensive care.
Chemioterapia. 1987 Dec;6(6):434-6.
6
[Pharmacokinetics and clinical experiences with a new aminoglycoside antibioticum: amikacin].[一种新型氨基糖苷类抗生素阿米卡星的药代动力学及临床经验]
Verh Dtsch Ges Inn Med. 1976;82 Pt 2:1684-6.
7
The efficacy of amikacin in the treatment of severe infections in a renal unit.阿米卡星在肾内科治疗严重感染中的疗效。
Chemioterapia. 1987 Jun;6(2 Suppl):386-9.
8
Replacement of gentamicin by amikacin as a means of decreasing gentamicin resistance of gram-negative rods in a neonatal intensive care unit.在新生儿重症监护病房中,用阿米卡星替代庆大霉素以降低革兰氏阴性杆菌对庆大霉素的耐药性。
Isr J Med Sci. 1983 Nov;19(11):1006-8.
9
[Amikacin in the treatment of hospital infections of the urinary tract caused by gram-negative bacilli resistant to gentamicin. Microbiological and clinical aspects].[阿米卡星治疗对庆大霉素耐药的革兰阴性杆菌所致医院内泌尿道感染。微生物学及临床方面]
Minerva Urol. 1981 Apr-Jun;33(2):85-90.
10
The efficacy and safety of isepamicin and ceftazidime compared with amikacin and ceftazidime in acute lower respiratory tract infection.异帕米星与头孢他啶联用对比阿米卡星与头孢他啶联用在急性下呼吸道感染中的疗效及安全性
J Chemother. 1995 Jun;7 Suppl 2:129-35.

引用本文的文献

1
Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis.β-内酰胺类抗生素单药治疗与β-内酰胺类-氨基糖苷类抗生素联合治疗败血症的比较
Cochrane Database Syst Rev. 2014 Jan 7;2014(1):CD003344. doi: 10.1002/14651858.CD003344.pub3.
2
Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials.β-内酰胺类单药治疗与β-内酰胺类-氨基糖苷类联合治疗对免疫功能正常患者败血症的疗效:随机试验的系统评价和荟萃分析
BMJ. 2004 Mar 20;328(7441):668. doi: 10.1136/bmj.38028.520995.63. Epub 2004 Mar 2.